previous compound ID: 2086 next compound
InChIKey: SHIBSTMRCDJXLN-KCZCNTNESA-N
SMILES: C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "J Goepp" "JW Hanrahan" "E Matthes" "D Rotin" "GW Carlile" "DY Thomas" "B Kus" "J Liao" "SD Macknight"

chemical graph of compound 2086





CID is 15478
synonyms found at PubChem are:
Digoxigenin, 1672-46-4, Lanadigenin, Digoxigenine, UNII-NQ1SX9LNAU, CHEBI:42098, HSDB 7108, NQ1SX9LNAU, EINECS 216-806-2, BRN 0096479, 3-beta,12-beta,14-Trihydroxy-card-20(22)-enolide, 3-beta,12,14-Trioxy-digen-(20:22)-olid [German], 3-beta,12,14-Trioxy-carden-(20:22)-olid [German], 3beta,12beta,14-trihydroxy-5beta-card-20(22)-enolide, Cardogenen-(20:22)-triol-(3-beta,12,14) [German], (3beta,5beta,12beta)-3,12,14-Trihydroxycard-20(22)-enolide, delta-sup(20:22)-3-beta,12-beta,14,21-Tetrahydroxynorcholenic acid lactone, 5-beta-CARD-20(22)-ENOLIDE, 3-beta,12-beta,14-TRIHYDROXY-, 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one, 4-(3,12,14-TRIHYDROXY-10,13-DIMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-17-YL)-5H-FURAN-2-ONE, SR-01000841253, Lanadigigenin, 1lke, 3|A-Digoxigenin, CAS-1672-46-4, 4j8t, 4j9a, Prestwick0_000883, Prestwick1_000883, Prestwick2_000883, Prestwick3_000883, bmse000735, Epitope ID:180303, 3-beta,12,14-Trioxy-carden-(20:22)-olid, 3-beta,12,14-Trioxy-digen-(20:22)-olid, CHEMBL1153, DSSTox_CID_30333, DSSTox_GSID_51778, SCHEMBL21105, BSPBio_000666, 5-18-04-00380 (Beilstein Handbook Reference), MLS002154050, SPBio_002885, AC1L25Z9, AC1Q69N3, BPBio1_000734, CARDOGENEN-(20:22)-TRIOL-(3-beta,12,14), Digoxigenin, analytical standard, DTXSID6051778, CTK8F9202, MolPort-004-955-165, SHIBSTMRCDJXLN-KCZCNTNESA-N, BDBM225707, CS337, HMS1570B08, HMS2097B08, HMS2233P09, HMS3714B08, HY-B1025, ZINC3982471, Tox21_303893, 2376AH, LMST01120008, AKOS015915909, CCG-220883, CS-4542, DB03671, NCGC00017309-03, NCGC00142481-02, NCGC00357149-01, AJ-47586, CC-26801, LS-52505, SMR001233370, ST056392, AB00513944, 6459-EP1441224A2, 6459-EP2269992A1, 6459-EP2272516A2, 6459-EP2277898A2, 6459-EP2298312A1, 6459-EP2316937A1, AB00513944_05, 5|A,20(22)-Cardenolide-3|A,12|A,14-triol, C-21538, 5beta,20(22)-Cardenolide-3beta,12beta,14-triol, J-010346, SR-01000841253-2, SR-01000841253-3, BRD-K18619710-001-03-7, I14-53600, 3beta,12beta,14-Trihydroxy-5beta,20(22)-cardenolide, (3b,5b,12b)-3,12,14-trihydroxycard-20(22)-enolide, Digoxigenin, European Pharmacopoeia (EP) Reference Standard, 3beta,12beta,14beta,21-Tetrahydroxy-20(22)-norcholenic acid lactone, Card-20(22)-enolide, 3,12,14-trihydroxy-, (3-beta,5-beta,12-beta)-, Card-20(22)-enolide, 3,12,14-trihydroxy-, (3-beta,5-beta,12-beta)- (9CI), 4-((1S,2S,5S,11S,15S,7R,10R,14R,16R)-5,11,16-trihydroxy-2,15-dimethyltetracycl o[8.7.0.0<2,7>.0<11,15>]heptadec-14-yl)-5-hydrofuran-2-one, 4-((3S,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one